AP2006003703A0 - Pharmaceutical compositions comprising a proton pump inhibitor and a prokinetic agent - Google Patents
Pharmaceutical compositions comprising a proton pump inhibitor and a prokinetic agentInfo
- Publication number
- AP2006003703A0 AP2006003703A0 AP2006003703A AP2006003703A AP2006003703A0 AP 2006003703 A0 AP2006003703 A0 AP 2006003703A0 AP 2006003703 A AP2006003703 A AP 2006003703A AP 2006003703 A AP2006003703 A AP 2006003703A AP 2006003703 A0 AP2006003703 A0 AP 2006003703A0
- Authority
- AP
- ARIPO
- Prior art keywords
- pharmaceutical compositions
- proton pump
- pump inhibitor
- prokinetic agent
- prokinetic
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 239000002325 prokinetic agent Substances 0.000 title 1
- 229940126409 proton pump inhibitor Drugs 0.000 title 1
- 239000000612 proton pump inhibitor Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN21DE2004 | 2004-01-06 | ||
| IN25DE2004 | 2004-01-06 | ||
| PCT/IN2005/000002 WO2005065664A1 (fr) | 2004-01-06 | 2005-01-05 | Compositions pharmaceutiques comprenant un inhibiteur de pompe a protons et un agent pro-cinetique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AP2006003703A0 true AP2006003703A0 (en) | 2006-08-31 |
Family
ID=34751863
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AP2006003703A AP2006003703A0 (en) | 2004-01-06 | 2005-01-05 | Pharmaceutical compositions comprising a proton pump inhibitor and a prokinetic agent |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20070160664A1 (fr) |
| EP (1) | EP1729743A1 (fr) |
| AP (1) | AP2006003703A0 (fr) |
| AU (1) | AU2005204014B2 (fr) |
| BR (1) | BRPI0506704A (fr) |
| CA (1) | CA2552627A1 (fr) |
| EA (1) | EA012261B1 (fr) |
| NZ (1) | NZ548780A (fr) |
| RS (1) | RS20050796A (fr) |
| WO (1) | WO2005065664A1 (fr) |
| ZA (1) | ZA200606409B (fr) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7981908B2 (en) | 2005-05-11 | 2011-07-19 | Vecta, Ltd. | Compositions and methods for inhibiting gastric acid secretion |
| US7803817B2 (en) * | 2005-05-11 | 2010-09-28 | Vecta, Ltd. | Composition and methods for inhibiting gastric acid secretion |
| AU2007278986B2 (en) * | 2006-07-25 | 2010-09-16 | Vecta, Ltd. | Compositions and methods for inhibiting gastric acid secretion using derivatives of small dicarboxylic acids in combination with PPI |
| BRPI0807046A2 (pt) | 2007-02-09 | 2015-05-26 | Tranzyme Pharma Inc | Composto, composição farmacêutica, métodos de tratar um distúrbio, uma doença cardiovascular e um paciente que sofre de motilidade gastrointestinal reduzida ou disfuncional e, kit. |
| WO2010038241A2 (fr) * | 2008-09-30 | 2010-04-08 | Panacea Biotec Limited | Compositions pharmaceutiques comprenant un inhibiteur de pompe à proton, un agent procinétique et un acide alginique |
| WO2011136750A1 (fr) * | 2010-04-26 | 2011-11-03 | Mahmut Bilgic | Compositions pharmaceutiques induisant un effet synergique |
| EP2601936A4 (fr) * | 2010-08-03 | 2014-03-19 | Eisai R&D Man Co Ltd | Composition comprimée |
| BRPI1103093A2 (pt) * | 2011-06-03 | 2013-07-02 | Eurofarma Laboratarios Ltda | composiÇço farmacÊutica oral e uso da composiÇço farmacÊutica oral |
| KR20130024644A (ko) * | 2011-08-31 | 2013-03-08 | 한국유나이티드제약 주식회사 | 이토프라이드 염산염을 함유하는 제어 방출성 경구 제제의 조성물 및 그의 제조방법 |
| US11000481B2 (en) | 2015-06-26 | 2021-05-11 | Korea United Pharm. Inc. | Composite preparation of mosapride and rabeprazole |
| EP4577201A1 (fr) * | 2022-08-24 | 2025-07-02 | Alkem Laboratories Limited | Compositions de mesdopetam |
| WO2024224407A1 (fr) * | 2023-04-28 | 2024-10-31 | Akums Drugs & Pharmaceuticals Limited | Formulation de granulés multicouches et procédé de préparation associé |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH08512322A (ja) * | 1993-07-06 | 1996-12-24 | メルク エンド カンパニー インコーポレーテッド | H▲下2▼拮抗剤−胃腸運動性の薬剤組合せ物 |
| SE9600072D0 (sv) * | 1996-01-08 | 1996-01-08 | Astra Ab | New oral formulation of two active ingredients II |
| JP2001507359A (ja) * | 1997-01-03 | 2001-06-05 | エラン コーポレーション ピーエルシー | 徐放性シサプリドミニ錠剤製剤 |
| US6521255B2 (en) * | 2000-01-13 | 2003-02-18 | Osmotica Corp. | Osmotic device containing ranitidine and a prokinetic agent |
| EP1596838A2 (fr) * | 2003-02-11 | 2005-11-23 | Torrent Pharmaceuticals Ltd | Compositions pharmaceutiques d'administration orale une fois par jour |
-
2005
- 2005-01-05 CA CA002552627A patent/CA2552627A1/fr not_active Abandoned
- 2005-01-05 NZ NZ548780A patent/NZ548780A/en unknown
- 2005-01-05 RS YUP-2005/0796A patent/RS20050796A/sr unknown
- 2005-01-05 WO PCT/IN2005/000002 patent/WO2005065664A1/fr not_active Ceased
- 2005-01-05 ZA ZA200606409A patent/ZA200606409B/en unknown
- 2005-01-05 EP EP05709158A patent/EP1729743A1/fr not_active Withdrawn
- 2005-01-05 BR BRPI0506704-9A patent/BRPI0506704A/pt not_active IP Right Cessation
- 2005-01-05 EA EA200601286A patent/EA012261B1/ru not_active IP Right Cessation
- 2005-01-05 AU AU2005204014A patent/AU2005204014B2/en not_active Ceased
- 2005-01-05 AP AP2006003703A patent/AP2006003703A0/xx unknown
-
2006
- 2006-07-06 US US11/482,186 patent/US20070160664A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CA2552627A1 (fr) | 2005-07-21 |
| NZ548780A (en) | 2008-09-26 |
| US20070160664A1 (en) | 2007-07-12 |
| BRPI0506704A (pt) | 2007-05-02 |
| AU2005204014B2 (en) | 2008-02-28 |
| EP1729743A1 (fr) | 2006-12-13 |
| WO2005065664A8 (fr) | 2005-10-20 |
| WO2005065664A1 (fr) | 2005-07-21 |
| EA012261B1 (ru) | 2009-08-28 |
| AU2005204014A1 (en) | 2005-07-21 |
| RS20050796A (sr) | 2007-08-03 |
| ZA200606409B (en) | 2008-06-25 |
| EA200601286A1 (ru) | 2007-02-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1742630A4 (fr) | Combinaison d'un inhibiteur de la pompe a protons, d'un agent tampon et d'un agent prokinetique | |
| PL2319308T3 (pl) | Grzybobójcza kombinacja substancji czynnych zawierająca fluoksastrobinę i inny środek grzybobójczy | |
| IL186944A (en) | Solid formulation of laxative and various aspects related to this formulation | |
| IL183658A0 (en) | Solid dosage form comprising proton pump inhibitor and suspension made thereof | |
| GB0413730D0 (en) | A pharmaceutical composition and its use | |
| IL179795A0 (en) | A pharmaceutical composition and its use | |
| PL1948149T3 (pl) | Preparat zawierający metforminę i wildagliptynę | |
| ZA200701557B (en) | Pharmaceutical compositions comprising diclofenac | |
| IL183986A0 (en) | Pharmaceutical compounds and compositions | |
| ZA200703148B (en) | Pharmaceutical compositions comprising a camtothecin derivate | |
| IL178417A0 (en) | Pharmaceutical compositions comprising a jnk inhibitor and cyclosporin | |
| IL199904A0 (en) | Compositions comprising a therapeutic agent and an alkoxy-polyethylene glycol and uses thereof | |
| IL213897A0 (en) | Ultrasound contrast agent dosage formulation | |
| AP2006003703A0 (en) | Pharmaceutical compositions comprising a proton pump inhibitor and a prokinetic agent | |
| PL1973423T3 (pl) | Preparat zawierający kompozycję zawierającą polifenole i izomaltulozę | |
| GB0413366D0 (en) | Binder-free photopolymerizable compositions | |
| ZA200700511B (en) | A pharmaceutical composition comprising gabapentin | |
| EP2015731A4 (fr) | Compositions pharmaceutiques contenant un médicament anti-inflammatoire non stéroïdien, un médicament antipyrétique et analgésique et un inhibiteur de la pompe à protons | |
| HU0401176D0 (en) | Prokinetic pharmaceutical composition | |
| IL178928A0 (en) | Pharmaceutical compositions comprising zd6474 | |
| AP3045A (en) | New association between agomelatine and a thymoregulatory agent and pharmaceutical compositions containing it | |
| PL380070A1 (pl) | Sposoby i kompozycje do doustnego podawania proleków inhibitorów pompy protonowej | |
| EP1759703A4 (fr) | Agent immunostimulateur et interf rogène | |
| GB0409779D0 (en) | New analgesic compositions and their administration | |
| GB0416679D0 (en) | Scaffold board tie |